These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13131780)

  • 1. [Possible testosterone therapy of uterine cancer].
    HUSSLEIN H
    Krebsarzt; 1952 Oct; 7(9-10):287. PubMed ID: 13131780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Integral therapy of cancer of the uterine cervix with massive doses of testosterone enanthate].
    ROSSI M; SILIOTTI I; GIAQUINTO M; MONTANARI G; GATTO A
    Minerva Med; 1958 Jun; 49(47):2355-62. PubMed ID: 13565666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies of androgen therapy of the myomatous uterus, with special reference to the involution of myoma].
    BLEIER W
    Geburtshilfe Frauenheilkd; 1957 May; 17(5):463-8. PubMed ID: 13438232
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sub-mucous fibroma treated by testosterone during 6 years followed by roentgenotherapy; results after 16 years].
    BECLERE C
    C R Soc Fr Gyncol; 1954 Dec; 24(9):330-2. PubMed ID: 14365097
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonotherapy of the recurrent carcinoma of the uterus].
    Graham R; Graham J; Hreshchyshyn M; Ross A
    Gynecol Prat; 1967; 18(6):591-5. PubMed ID: 5621518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in serum aldolase caused by hormone therapy of uterine cancer patients].
    FERABOLI M; FOTI M
    Minerva Ginecol; 1955 Jun; 7(12):139-40. PubMed ID: 13253335
    [No Abstract]   [Full Text] [Related]  

  • 7. Testosterone therapy in castrate-resistant prostate cancer: a possible new approach.
    Gardiner RA; Sweeney C; Tilley WD
    Eur Urol; 2009 Aug; 56(2):245-6. PubMed ID: 19409691
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of changes in hormonal medium in cancer of uterine cervix].
    GOMEZ MONT F; MONTANO G; MUNGUIA H; FRANCO E
    Rev Invest Clin; 1957; 9(2-3):403-17. PubMed ID: 13485626
    [No Abstract]   [Full Text] [Related]  

  • 9. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
    Morgentaler A
    J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone therapy in the ageing male: what about the prostate?
    Schultheiss D; Machtens S; Jonas U
    Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
    Halland A; Jønler M; Pedersen KV
    Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy and prostate cancer.
    Morgentaler A
    Urol Clin North Am; 2007 Nov; 34(4):555-63, vii. PubMed ID: 17983895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy and the risk of prostate cancer: a perspective view.
    Barqawi AB; Crawford ED
    Int J Impot Res; 2005; 17(5):462-3. PubMed ID: 15889127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium and magnesium excretion in urine in breast cancer as evaluation of testosterone therapy].
    STRIEBEL A; VON PLANTA P; VIOLLIER G
    Schweiz Med Wochenschr; 1955 Feb; 85(8):167-70. PubMed ID: 14358628
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone replacement therapy in hypogonadal men and prostate cancer risk.
    Kirby R; Gould D
    BJU Int; 2005 Sep; 96(4):471-2. PubMed ID: 16104891
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer following testosterone replacement in Klinefelter syndrome.
    Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
    ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    Barqawi A; Crawford ED
    Int J Impot Res; 2006; 18(4):323-8. PubMed ID: 16281043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.